Analysts’ price target changes for Tuesday, March 24th:
Abivax (NASDAQ:ABVX) had its price target raised by Barclays PLC from $142.00 to $148.00. They currently have an overweight rating on the stock.
ProFrac (NASDAQ:ACDC) had its price target increased by Morgan Stanley from $4.00 to $5.00. They currently have an underweight rating on the stock.
Grupo Aeromexico (NYSE:AERO) had its price target cut by Barclays PLC from $32.00 to $25.00. Barclays PLC currently has an overweight rating on the stock.
Alkermes (NASDAQ:ALKS) had its price target cut by Piper Sandler from $45.00 to $43.00. They currently have an overweight rating on the stock.
Alvotech (NASDAQ:ALVO) had its target price trimmed by UBS Group AG from $10.00 to $6.00. They currently have a buy rating on the stock.
Alvotech (NASDAQ:ALVO) had its target price trimmed by Barclays PLC from $5.00 to $4.00. Barclays PLC currently has an underweight rating on the stock.
APA (NASDAQ:APA) had its target price increased by Evercore Inc from $25.00 to $40.00. The firm currently has a neutral rating on the stock.
Apogee Therapeutics (NASDAQ:APGE) had its price target boosted by Guggenheim from $130.00 to $160.00. Guggenheim currently has a buy rating on the stock.
Apogee Therapeutics (NASDAQ:APGE) had its target price raised by Citigroup Inc. from $95.00 to $125.00. They currently have a buy rating on the stock.
Apogee Therapeutics (NASDAQ:APGE) had its price target boosted by Canaccord Genuity Group Inc. from $89.00 to $130.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
Apple Hospitality REIT (NYSE:APLE) had its target price cut by Wells Fargo & Company from $13.00 to $12.00. The firm currently has an equal weight rating on the stock.
Apollo Global Management (NYSE:APO) had its target price cut by BMO Capital Markets from $135.00 to $116.00. BMO Capital Markets currently has a market perform rating on the stock.
Ares Management (NYSE:ARES) had its price target trimmed by BMO Capital Markets from $140.00 to $112.00. BMO Capital Markets currently has a market perform rating on the stock.
Bunge Global (NYSE:BG) had its target price boosted by JPMorgan Chase & Co. from $130.00 to $134.00. They currently have an overweight rating on the stock.
Brixmor Property Group (NYSE:BRX) had its price target raised by Scotiabank from $29.00 to $33.00. Scotiabank currently has a sector outperform rating on the stock.
Blackstone (NYSE:BX) had its price target cut by BMO Capital Markets from $165.00 to $126.00. BMO Capital Markets currently has an outperform rating on the stock.
Cabaletta Bio (NASDAQ:CABA) had its target price cut by Morgan Stanley from $14.00 to $13.00. Morgan Stanley currently has an overweight rating on the stock.
Cabaletta Bio (NASDAQ:CABA) had its price target boosted by Guggenheim from $15.00 to $16.00. Guggenheim currently has a buy rating on the stock.
Camtek (NASDAQ:CAMT) had its price target boosted by Morgan Stanley from $151.00 to $161.00. They currently have an equal weight rating on the stock.
Carnival (NYSE:CCL) had its target price cut by Barclays PLC from $37.00 to $36.00. The firm currently has an overweight rating on the stock.
Core Natural Resources (NYSE:CNR) had its target price raised by UBS Group AG from $109.00 to $115.00. The firm currently has a buy rating on the stock.
Corero Network Security (LON:CNS) had its target price increased by Canaccord Genuity Group Inc. from GBX 19 to GBX 20. They currently have a buy rating on the stock.
Context Therapeutics (NASDAQ:CNTX) had its price target raised by Piper Sandler from $4.00 to $7.00. Piper Sandler currently has an overweight rating on the stock.
Copa (NYSE:CPA) had its price target lowered by Barclays PLC from $185.00 to $165.00. Barclays PLC currently has an overweight rating on the stock.
Croda International (LON:CRDA) had its price target trimmed by Deutsche Bank Aktiengesellschaft from GBX 3,100 to GBX 3,000. Deutsche Bank Aktiengesellschaft currently has a hold rating on the stock.
Clearway Energy (NYSE:CWEN.A) had its price target boosted by UBS Group AG from $39.00 to $44.00. They currently have a buy rating on the stock.
Darling Ingredients (NYSE:DAR) had its price target raised by JPMorgan Chase & Co. from $59.00 to $69.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Estee Lauder Companies (NYSE:EL) had its target price lowered by Wells Fargo & Company from $105.00 to $90.00. They currently have an equal weight rating on the stock.
Entain (LON:ENT) had its target price raised by Deutsche Bank Aktiengesellschaft from GBX 1,029 to GBX 1,055. The firm currently has a buy rating on the stock.
Federal Realty Investment Trust (NYSE:FRT) had its target price boosted by Scotiabank from $113.00 to $118.00. Scotiabank currently has a sector outperform rating on the stock.
FTAI Aviation (NASDAQ:FTAI) had its target price raised by Morgan Stanley from $266.00 to $293.00. The firm currently has an overweight rating on the stock.
The Gym Group (LON:GYM) had its target price raised by Berenberg Bank from GBX 230 to GBX 235. Berenberg Bank currently has a buy rating on the stock.
HeartSciences (NASDAQ:HSCS) had its price target lowered by Ascendiant Capital Markets from $9.00 to $8.00. They currently have a buy rating on the stock.
Host Hotels & Resorts (NASDAQ:HST) had its price target raised by Wells Fargo & Company from $19.00 to $20.00. Wells Fargo & Company currently has an overweight rating on the stock.
Ibstock (LON:IBST) had its price target trimmed by Deutsche Bank Aktiengesellschaft from GBX 144 to GBX 110. The firm currently has a hold rating on the stock.
Insmed (NASDAQ:INSM) had its price target boosted by Bank of America Corporation from $211.00 to $213.00. Bank of America Corporation currently has a buy rating on the stock.
Insmed (NASDAQ:INSM) had its price target raised by Leerink Partners from $210.00 to $215.00. The firm currently has an outperform rating on the stock.
Insmed (NASDAQ:INSM) had its target price boosted by Stifel Nicolaus from $205.00 to $208.00. Stifel Nicolaus currently has a buy rating on the stock.
Kyndryl (NYSE:KD) had its price target reduced by Morgan Stanley from $28.00 to $13.00. The firm currently has an equal weight rating on the stock.
Kimco Realty (NYSE:KIM) had its price target boosted by Scotiabank from $22.00 to $24.00. The firm currently has a sector perform rating on the stock.
Kinder Morgan (NYSE:KMI) had its price target boosted by Jefferies Financial Group Inc. from $31.00 to $36.00. The firm currently has a hold rating on the stock.
Legal & General Group (LON:LGEN) had its target price increased by Citigroup Inc. from GBX 243 to GBX 249. The firm currently has a neutral rating on the stock.
Ligand Pharmaceuticals (NASDAQ:LGND) had its price target raised by Citigroup Inc. from $270.00 to $276.00. They currently have a buy rating on the stock.
LATAM Airlines Group (NYSE:LTM) had its target price lowered by Barclays PLC from $75.00 to $67.00. The firm currently has an overweight rating on the stock.
Lamb Weston (NYSE:LW) had its target price lowered by JPMorgan Chase & Co. from $50.00 to $44.00. They currently have a neutral rating on the stock.
Michelmersh Brick (LON:MBH) had its target price lowered by Canaccord Genuity Group Inc. from GBX 150 to GBX 130. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
M&G (LON:MNG) had its target price raised by Citigroup Inc. from GBX 260 to GBX 288. They currently have a neutral rating on the stock.
nCino (NASDAQ:NCNO) had its price target lowered by Barclays PLC from $34.00 to $21.00. They currently have an overweight rating on the stock.
Northern Oil and Gas (NYSE:NOG) had its price target boosted by Bank of America Corporation from $27.00 to $32.00. The firm currently has a buy rating on the stock.
New York Times (NYSE:NYT) had its target price increased by Citigroup Inc. from $77.00 to $94.00. The firm currently has a buy rating on the stock.
Ondas (NASDAQ:ONDS) had its price target boosted by Needham & Company LLC from $17.00 to $23.00. Needham & Company LLC currently has a buy rating on the stock.
Oxford Nanopore Technologies (LON:ONT) had its target price trimmed by Royal Bank Of Canada from GBX 300 to GBX 225. They currently have an outperform rating on the stock.
Pebblebrook Hotel Trust (NYSE:PEB) had its price target lowered by Wells Fargo & Company from $13.00 to $12.00. They currently have an equal weight rating on the stock.
Pfizer (NYSE:PFE) had its target price boosted by Guggenheim from $35.00 to $36.00. The firm currently has a buy rating on the stock.
Personal Group (LON:PGH) had its price target cut by Canaccord Genuity Group Inc. from GBX 416 to GBX 415. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
Progressive (NYSE:PGR) had its target price lowered by Jefferies Financial Group Inc. from $216.00 to $215.00. Jefferies Financial Group Inc. currently has a hold rating on the stock.
Park Hotels & Resorts (NYSE:PK) had its price target reduced by Wells Fargo & Company from $11.00 to $10.00. Wells Fargo & Company currently has an equal weight rating on the stock.
PVH (NYSE:PVH) had its price target lowered by Telsey Advisory Group from $82.00 to $74.00. The firm currently has a market perform rating on the stock.
Palvella Therapeutics (NASDAQ:PVLA) had its target price boosted by HC Wainwright from $255.00 to $270.00. The firm currently has a buy rating on the stock.
Pyxis Oncology (NASDAQ:PYXS) had its target price reduced by Stifel Nicolaus from $9.00 to $8.00. They currently have a buy rating on the stock.
Regency Centers (NASDAQ:REG) had its price target increased by Scotiabank from $76.00 to $82.00. Scotiabank currently has a sector perform rating on the stock.
Ryman Hospitality Properties (NYSE:RHP) had its target price reduced by Wells Fargo & Company from $109.00 to $105.00. They currently have an overweight rating on the stock.
The Sage Group (LON:SGE) had its price target trimmed by Jefferies Financial Group Inc. from GBX 1,350 to GBX 1,100. The firm currently has a buy rating on the stock.
Sunstone Hotel Investors (NYSE:SHO) had its target price reduced by Wells Fargo & Company from $11.00 to $10.00. They currently have an overweight rating on the stock.
Tanger (NYSE:SKT) had its price target boosted by Scotiabank from $34.00 to $36.00. They currently have a sector perform rating on the stock.
SL Green Realty (NYSE:SLG) had its price target lowered by Citigroup Inc. from $55.00 to $45.00. Citigroup Inc. currently has a buy rating on the stock.
Super Micro Computer (NASDAQ:SMCI) had its price target lowered by Citigroup Inc. from $39.00 to $25.00. They currently have a neutral rating on the stock.
Super Micro Computer (NASDAQ:SMCI) had its price target reduced by Bank of America Corporation from $34.00 to $24.00. They currently have an underperform rating on the stock.
Simon Property Group (NYSE:SPG) had its target price raised by Scotiabank from $189.00 to $192.00. Scotiabank currently has a sector perform rating on the stock.
Sunoco (NYSE:SUN) had its price target increased by JPMorgan Chase & Co. from $66.00 to $73.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Travis Perkins (LON:TPK) had its price target lowered by JPMorgan Chase & Co. from GBX 712 to GBX 680. They currently have an overweight rating on the stock.
Targa Resources (NYSE:TRGP) had its target price raised by UBS Group AG from $228.00 to $280.00. They currently have a buy rating on the stock.
Controladora Vuela Compania de Aviacion (NYSE:VLRS) had its target price cut by Barclays PLC from $12.00 to $10.00. Barclays PLC currently has an overweight rating on the stock.
WEC Energy Group (NYSE:WEC) had its price target raised by Barclays PLC from $110.00 to $111.00. The firm currently has an equal weight rating on the stock.
Xcel Energy (NASDAQ:XEL) had its price target cut by UBS Group AG from $93.00 to $89.00. They currently have a buy rating on the stock.
XPENG (NYSE:XPEV) had its price target lowered by Barclays PLC from $17.00 to $16.00. They currently have an underweight rating on the stock.
Receive News & Ratings for Abivax SA Sponsored ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abivax SA Sponsored ADR and related companies with MarketBeat.com's FREE daily email newsletter.
